4//SEC Filing
COLLIER RICHARD T 4
Accession 0001567619-22-021312
CIK 0001559053other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 9:47 PM ET
Size
16.1 KB
Accession
0001567619-22-021312
Insider Transaction Report
Form 4
COLLIER RICHARD T
Director
Transactions
- Exercise/Conversion
Ordinary Shares, par value $0.01 per share
2022-12-05$6.41/sh+5,000$32,050→ 6,219 total - Sale
Ordinary Shares, par value $0.01 per share
2022-12-05$62.71/sh−576$36,121→ 2,815 total - Sale
Ordinary Shares, par value $0.01 per share
2022-12-05$60.28/sh−1,915$115,429→ 4,304 total - Sale
Ordinary Shares, par value $0.01 per share
2022-12-05$61.13/sh−913$55,809→ 3,391 total - Sale
Ordinary Shares, par value $0.01 per share
2022-12-05$63.83/sh−647$41,296→ 2,168 total - Sale
Ordinary Shares, par value $0.01 per share
2022-12-05$65.02/sh−949$61,701→ 1,219 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-12-05−5,000→ 5,000 totalExercise: $6.41From: 2014-01-29Exp: 2023-01-29→ Ordinary Shares (5,000 underlying)
Footnotes (7)
- [F1]The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The transaction was executed in multiple trades in prices ranging from $59.72 to $60.67, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 6 of this Form 4.
- [F3]The transaction was executed in multiple trades in prices ranging from $60.87 to $61.65, inclusive.
- [F4]The transaction was executed in multiple trades in prices ranging from $62.19 to $63.06, inclusive.
- [F5]The transaction was executed in multiple trades in prices ranging from $63.465 to $64.145, inclusive.
- [F6]The transaction was executed in multiple trades in prices ranging from $64.66 to $65.62, inclusive.
- [F7]The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately two months and be forfeited to the extent it is not exercised on or prior to January 29, 2023.
Documents
Issuer
PROTHENA CORP PUBLIC LTD CO
CIK 0001559053
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001110751
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 9:47 PM ET
- Size
- 16.1 KB